Literature DB >> 18022232

Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma.

Katy J McCann1, Christian H Ottensmeier, Alice Callard, Catherine M Radcliffe, David J Harvey, Raymond A Dwek, Pauline M Rudd, Brian J Sutton, Paul Hobby, Freda K Stevenson.   

Abstract

Follicular lymphoma (FL) generally expresses immunoglobulin (Ig) with somatically mutated variable (V) region genes. Surprisingly, these almost always carry introduced motifs available for N-glycosylation (Asn-X-Ser/Thr). Introduced motifs are uncommon on normal B cells, but are on other germinal center (GC)-associated B-cell malignancies suggesting a site-specific role. They are not evident in mutated chronic lymphocytic leukemia (CLL) or myeloma. Recently, we found that the glycosylation sites are unusual in containing oligomannose glycans, which are apparently displayed on tumor cell surface IgM. This suggests a potential interaction with a mannose receptor in the GC. However, natural N-glycosylation sites exist in germline (GL) V region genes, particularly the V4-34 gene expressed by normal B cells and by some malignancies, including CLL, potentially undermining the selective importance for FL. To compare oligosaccharide addition at the introduced and natural sites, we expressed V region genes as single chain Fv (scFv) and analyzed the added glycans. In contrast to introduced sites, which were oligomannosylated, the natural GL motif in the V4-34 sequence had no added sugars. The remarkable selective glycosylation within the heavy chain V region gene of FL apparently permits only limited processing to oligomannose at somatically mutated motifs, creating a feature exploitable by GC lymphomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022232     DOI: 10.1016/j.molimm.2007.10.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  23 in total

1.  Clonal relationships between thyroid-stimulating hormone receptor-stimulating antibodies illustrate the effect of hypermutation on antibody function.

Authors:  Carolyn J Padoa; Sanne L Larsen; Christiane S Hampe; Jacqueline A Gilbert; Elif Dagdan; Laszlo Hegedus; Deborah Dunn-Walters; J Paul Banga
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

Review 2.  Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?

Authors:  Nathan Fowler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.

Authors:  Janice M Spence; Andrew Abumoussa; John P Spence; W Richard Burack
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

Review 4.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

5.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

6.  Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.

Authors:  Fleur S van de Bovenkamp; Ninotska I L Derksen; Pleuni Ooijevaar-de Heer; Karin A van Schie; Simone Kruithof; Magdalena A Berkowska; C Ellen van der Schoot; Hanna IJspeert; Mirjam van der Burg; Ann Gils; Lise Hafkenscheid; René E M Toes; Yoann Rombouts; Rosina Plomp; Manfred Wuhrer; S Marieke van Ham; Gestur Vidarsson; Theo Rispens
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

7.  IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Authors:  Mariette Odabashian; Emanuela Carlotti; Shamzah Araf; Jessica Okosun; Filomena Spada; John G Gribben; Francesco Forconi; Freda K Stevenson; Mariarita Calaminici; Sergey Krysov
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

8.  Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.

Authors:  Emilie Mamessier; Charlotte Drevet; Florence Broussais-Guillaumot; Marie-Laure Mollichella; Sylvain Garciaz; Sandrine Roulland; Maxime Benchetrit; Bertrand Nadel; Luc Xerri
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

9.  Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.

Authors:  Vania Coelho; Sergey Krysov; Amir M Ghaemmaghami; Mohamed Emara; Kathleen N Potter; Peter Johnson; Graham Packham; Luisa Martinez-Pomares; Freda K Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 10.  The tumour microenvironment in B cell lymphomas.

Authors:  David W Scott; Randy D Gascoyne
Journal:  Nat Rev Cancer       Date:  2014-07-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.